Ousia Pharma
PrivateLast Round
Seed
May 6, 2025
Total Funding Raised
$17.15M
Company Overview
Ousia Pharma is a biotechnology company that develops innovative peptide-drug conjugates for the treatment of obesity and metabolic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ousia Pharma Comparables
Compare Ousia Pharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Roche Holding | 70% | |
| Zealand Pharma | 69% | |
| Novo Nordisk | 68% | |
Ousia Pharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | May 6, 2025 | ||||
| Pre Seed | Mar 17, 2023 |
Key People
Founding team and executive leadership
Ousia Pharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Omega Funds | Seed |
| BioInnovation Institute | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 565% MoM.
- Sep 4, 2025
Grew 100% QoQ from 4 to 8 employees.
Ousia Pharma Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Ousia Pharma's valuation, stock price, and market status.